drugset / Trial / NCT00403624
Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in Rectal Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Primary objective: \- To evaluate the rate of responses to neoadjuvant therapy + radiotherapy Secondary objective: \- tolerability (toxicity) and time to progression
Timeline
- Start
- 2001-07
- Primary completion
- 2005-11
- Completion
- 2005-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxaliplatin | Small molecule | — | — |